Cargando…

Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication

Background: Once-daily treatment formulation is associated with better adherence in comparison to more complex medication regimens. The study aimed to detect the extent of adherence to pharmacotherapy in Parkinson disease (PD) patients who take a minimum of three daily doses of drugs, and to identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Straka, Igor, Minár, Michal, Škorvánek, Matej, Grofik, Milan, Danterová, Katarína, Benetin, Ján, Kurča, Egon, Gažová, Andrea, Boleková, Veronika, Wyman-Chick, Kathryn A., Kyselovič, Ján, Valkovič, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684743/ https://www.ncbi.nlm.nih.gov/pubmed/31417484 http://dx.doi.org/10.3389/fneur.2019.00799

Ejemplares similares

Effect of Pillbox Organizers with Alarms on Adherence to Pharmacotherapy in Parkinson Disease Patients Taking Three and More Daily Doses of Dopaminergic Medications
por: Straka, Igor, et al.
Publicado: (2022)

Clinical aspects of adherence to pharmacotherapy in Parkinson disease: A PRISMA-compliant systematic review
por: Straka, Igor, et al.
Publicado: (2018)

Validation of the Official Slovak Version of the Unified Dyskinesia Rating Scale (UDysRS)
por: Skorvanek, Matej, et al.
Publicado: (2015)

Atypical presentation of Charcot-Marie-Tooth disease type 1C with a new mutation: a case report
por: Turčanová Koprušáková, Monika, et al.
Publicado: (2021)

Alzheimer’s Disease-Associated SNP rs708727 in SLC41A1 May Increase Risk for Parkinson’s Disease: Report from Enlarged Slovak Study
por: Cibulka, Michal, et al.
Publicado: (2022)

Tolcapone improves outcomes in patients with Parkinson disease treated by levodopa/carbidopa intestinal gel: A pilot study
por: Valkovič, Peter, et al.
Publicado: (2022)

Pain in Parkinson´s Disease: A Cross-Sectional Study of Its Prevalence, Types, and Relationship to Depression and Quality of Life
por: Valkovic, Peter, et al.
Publicado: (2015)

Nonmotor Symptoms in Early- and Advanced-Stage Parkinson's Disease Patients on Dopaminergic Therapy: How Do They Correlate with Quality of Life?
por: Valkovic, Peter, et al.
Publicado: (2014)

Levodopa-Carbidopa Intestinal Gel Improves Symptoms of Orthostatic Hypotension in Patients with Parkinson’s Disease—Prospective Pilot Interventional Study
por: Stanková, Simona, et al.
Publicado: (2022)

TRP Channels Expression Profile in Human End-Stage Heart Failure
por: Dragún, Martin, et al.
Publicado: (2019)

Gait Disorders Questionnaire–Promising Tool for Virtual Reality Designing in Patients With Parkinson's Disease
por: Kosutzka, Zuzana, et al.
Publicado: (2019)

Clinical study of effectiveness and safety of CELcomplex(®) containing Cucurbita Pepo Seed extract and Flax and Casuarina on stress urinary incontinence in women
por: Gažová, Andrea, et al.
Publicado: (2018)

Imaging Methods Applicable in the Diagnostics of Alzheimer’s Disease, Considering the Involvement of Insulin Resistance
por: Hnilicova, Petra, et al.
Publicado: (2023)

Impact of the COVID-19 outbreak on neurological consultation in an emergency department
por: Maretta, Milan, et al.
Publicado: (2022)

Normalization strategy for selection of reference genes for RT-qPCR analysis in left ventricles of failing human hearts
por: Červenák, Zdenko, et al.
Publicado: (2022)

Evaluation of efficacy and safety of systemic and topical intra-articular administration of tranexamic acid in primary unilateral total hip arthroplasty
por: Juraj, Masaryk, et al.
Publicado: (2021)

Predictive value of CHA(2)DS(2)-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant)
por: Gažová, Andrea, et al.
Publicado: (2019)

SNPs rs11240569, rs708727, and rs823156 in SLC41A1 Do Not Discriminate Between Slovak Patients with Idiopathic Parkinson’s Disease and Healthy Controls: Statistics and Machine-Learning Evidence
por: Cibulka, Michal, et al.
Publicado: (2019)

Multivessel Coronary Disease and Severe Atherosclerotic Aorta: Real-World Experience
por: Gasparovic, Ivo, et al.
Publicado: (2023)

Thyroid-Induced Worsening of Parkinsonian Tremor Resistant to Drugs and Subthalamic Nucleus Deep Brain Stimulation
por: Minár, Michal, et al.
Publicado: (2014)

Pharmacological Approaches and Regeneration of Bone Defects with Dental Pulp Stem Cells
por: Adamička, M., et al.
Publicado: (2021)

Effect of Atorvastatin on Angiogenesis-Related Genes VEGF-A, HGF and IGF-1 and the Modulation of PI3K/AKT/mTOR Transcripts in Bone-Marrow-Derived Mesenchymal Stem Cells
por: Adamičková, Adriana, et al.
Publicado: (2023)

Aerobic-Strength Exercise Improves Metabolism and Clinical State in Parkinson’s Disease Patients
por: Krumpolec, Patrik, et al.
Publicado: (2017)

Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased risk of death
por: Smaha, Juraj, et al.
Publicado: (2022)

Factors associated with psychiatric and physical comorbidities in bipolar disorder: a nationwide multicenter cross-sectional observational study
por: Dragasek, Jozef, et al.
Publicado: (2023)

Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson’s Disease and Other Synucleinopathies
por: Skorvanek, Matej, et al.
Publicado: (2018)

Impairment of endothelial function in Parkinson’s disease
por: Kollár, Branislav, et al.
Publicado: (2022)

Psychosocial Impact of Huntington’s Disease and Incentives to Improve Care for Affected Families in the Underserved Region of the Slovak Republic
por: Hubčíková, Katarína, et al.
Publicado: (2022)

Progressive choreodystonia in X‐linked hyper‐IgM immunodeficiency: a rare but recurrent presentation
por: Škorvánek, Matej, et al.
Publicado: (2022)

Tacrolimus-induced parkinsonism in a patient after liver transplantation – case report
por: Gmitterová, Karin, et al.
Publicado: (2018)

Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports
por: Ordak, Michal, et al.
Publicado: (2021)

Cost-Effectiveness of Pharmacotherapy to Reduce Obesity
por: Veerman, J. Lennert, et al.
Publicado: (2011)

Taking the daily grind out of HIV prevention
por: Zydowsky, Thomas M.
Publicado: (2020)

sRage plasma level in association with multiple sclerosis risk in Slovak population
por: Dobrota, Dusan, et al.
Publicado: (2015)

Pharmacotherapy for Fibromyalgia
por: Smith, Howard S., et al.
Publicado: (2011)

Antiglaucoma pharmacotherapy
por: Tătaru, CP, et al.
Publicado: (2012)

Pharmacotherapies for COPD
por: Ejiofor, Stan, et al.
Publicado: (2013)

Pharmacotherapy for Retinoblastoma
por: Shahsavari, Mohsen, et al.
Publicado: (2009)

Pharmacotherapy for Obesity
por: Joo, Jong Kil, et al.
Publicado: (2014)

Pharmacotherapy for Nocturia
por: Andersson, Karl-Erik, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_puv1g941j5mfd7gq6qvkg94pi2